From Brief to Shelf in 90 Days: How a European Brand Launched Private-Label Skincare with One OEM Partner
Every month, hundreds of beauty brands start with the same sentence: "We have the brand, we need the product." Most of them quietly disappear inside the first year. This is the story of how one European DTC brand — let's call them LUMIÉ — went from a blank brief to a live product range in 90 days, with a single OEM partner and zero inventory risk at launch.
Day 1–10: The brief and the reality check
LUMIÉ's founder came with a clear idea: a 4-SKU clean skincare range (cleanser, serum, moisturizer, SPF) priced in the premium-masstige band. The first OEM meeting did not start with formulas. It started with three questions:
- What are your target markets and their regulatory routes? (EU CPNP via a responsible person — in this case, the brand's own EU entity.)
- Which of your 4 SKUs are "functional" anywhere? (The SPF crossed into the regulated zone immediately.)
- What is your honest launch MOQ?
The answers shaped everything: the SPF would be the last SKU to launch, the serum would carry the brand story, and the cleanser would be the volume play.
Day 11–35: Sampling, not guessing
The OEM's in-house lab ran three rounds of sampling. Round one tested the base textures; round two dialed in the hero actives (niacinamide 5% serum, ceramide moisturizer); round three locked the fragrances. Key discipline: the founder never changed the brief mid-sampling. Every tweak was written down, costed and approved — no verbal "can you just…" requests.
This is where a real R&D center pays for itself. The OEM's 600㎡ development lab meant formulations, stability screening and packaging fit-checks happened under one roof, cutting two weeks off a typical outsourced-lab timeline.
Day 36–60: Compliance in parallel, not at the end
While production samples ran, the regulatory track moved in parallel:
- Ingredient list locked and checked against EU Annex II/III restrictions.
- CPNP notification prepared for the first 3 SKUs, filed as soon as formulas were final.
- Label artwork drafted in English, French and German, reviewed against the EU labelling regulation before print.
- Packaging stability and transport tests scheduled with the batch production.
The lesson: brands that treat compliance as a final step lose 3–4 weeks; brands that run it in parallel hit their launch window.
Day 61–80: Production and the first sale
Batch production ran, with the OEM's QC releasing each lot against the agreed specification sheet. LUMIÉ received batch records, COAs, and the export file pack. The first units went not to a warehouse but to 200 micro-influencers — a seeding campaign that produced UGC before the official launch day.
Day 81–90: Live, and learning
The range went live with the serum as the hero SKU, the cleanser as the entry price point, and the SPF queued for the next cycle (its regulated status needed an extra month). First-month results told a clear story: the serum outperformed projections, the SPF delay cost some cross-sell but protected compliance.
What made it work
- One partner, full chain. Formulation, sampling, stability, production, QC and export paperwork from a single source removed the hand-off friction that kills most launches.
- The brief never moved. Disciplined change control kept the 90-day clock intact.
- Compliance ran parallel. CPNP and labelling were filed before the first pallet was packed.
- Launch MOQ matched reality. No dead stock, no forced discounts, no cash-flow shock.
The takeaway for new brands
A 90-day launch is realistic when three things are true: your range is small (3–5 SKUs), your OEM has in-house R&D and an export-ready compliance team, and you — the founder — make decisions fast and don't reopen them. If any of those three is missing, add two weeks per missing piece. And if your OEM cannot show you recent EU projects with CPNP filings, that is your signal to keep looking.
Related 8OEM resources
- Cosmetic OEM & ODM manufacturing — Full-service OEM/ODM: formulation, filling, packaging, export compliance.
- Free sampling & quotation — How sampling, revisions and approval work before mass production.
- Certifications we hold — ISO 22716, FDA-registered facility, and what each certificate actually covers.